mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.007 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.008 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |